Financial Instruments - Schedule of Available-for-Sale Financial Instruments (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Cash equivalents:
Amortized Cost	$ 209,845	$ 182,571
Marketable securities:
Amortized Cost	132,390	229,488
Unrealized Gain	4	140
Unrealized Losses	(763)	(867)
Fair Value	131,631	228,761
Corporate securities
Marketable securities:
Amortized Cost	110,948	199,084
Unrealized Gain	1	115
Unrealized Losses	(681)	(819)
Fair Value	110,268	198,380
U.S. treasury and agency securities
Marketable securities:
Amortized Cost	21,442	30,404
Unrealized Gain	3	25
Unrealized Losses	(82)	(48)
Fair Value	$ 21,363	30,381
Cash equivalents
Cash equivalents:
Amortized Cost		1,213
Unrealized Gain		0
Unrealized Losses		(1)
Fair Value		1,212
Corporate securities
Cash equivalents:
Amortized Cost		1,213
Unrealized Gain		0
Unrealized Losses		(1)
Fair Value		$ 1,212